Deep Learning Prediction of Promoter Mutation Status in Thyroid Cancer Using Histologic Images.

Journal: Medicina (Kaunas, Lithuania)
Published Date:

Abstract

objectives: Telomerase reverse transcriptase () promoter mutation, found in a subset of patients with thyroid cancer, is strongly associated with aggressive biologic behavior. Predicting promoter mutation is thus necessary for the prognostic stratification of thyroid cancer patients. In this study, we evaluate promoter mutation status in thyroid cancer through the deep learning approach using histologic images. Our analysis included 13 consecutive surgically resected thyroid cancers with promoter mutations (either C228T or C250T) and 12 randomly selected surgically resected thyroid cancers with a wild-type promoter. Our deep learning model was created using a two-step cascade approach. First, tumor areas were identified using convolutional neural networks (CNNs), and then promoter mutations within tumor areas were predicted using the CNN-recurrent neural network (CRNN) model. : Using the hue-saturation-value (HSV)-strong color transformation scheme, the overall experiment results show 99.9% sensitivity and 60% specificity (improvements of approximately 25% and 37%, respectively, compared to image normalization as a baseline model) in predicting mutations. : Highly sensitive screening for promoter mutations is possible using histologic image analysis based on deep learning. This approach will help improve the classification of thyroid cancer patients according to the biologic behavior of tumors.

Authors

  • Jinhee Kim
    Lab of Cell Differentiation Research, College of Korean Medicine, Gachon University, Seongnam, Republic of Korea.
  • Seokhwan Ko
    CAIDE Systems Inc., 110 Canal St., Lowell, MA, 01852, USA.
  • Moonsik Kim
    Department of Pathology, Kyungpook National University School of Medicine, Kyungpook National University Chilgok Hospital, Daegu 41404, Republic of Korea.
  • Nora Jee-Young Park
    Department of Pathology, Kyungpook National University School of Medicine, Kyungpook National University Chilgok Hospital, Daegu 41404, Republic of Korea.
  • Hyungsoo Han
    Clinical Omics Institute, Kyungpook National University, Daegu 41405, Republic of Korea.
  • Junghwan Cho
    CAIDE Systems Inc., 110 Canal St., Lowell, MA, 01852, USA. jcho@caidesystems.com.
  • Ji Young Park
    Division of Gastroenterology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.